The U.S. Food and Drug Administration has approved Cymbalta for chronic back pain and osteoarthritis pain, according to a FDA news release. Cymbalta, which was first used to treat major depressive ...
Regulators in the USA have cancelled a meeting to review a proposed new indication for Eli Lilly’s blockbuster antidepressant Cymbalta. Regulators in the USA have cancelled a meeting to review a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback